 | • レポートコード：MRC2-11QY02978 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は基底細胞母斑症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（イトラコナゾール、パチデギブ塩酸塩、REM-001、TG-1042、トリファロテン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別基底細胞母斑症候群治療薬の競争状況、市場シェア ・世界の基底細胞母斑症候群治療薬市場：種類別市場規模 2015年-2020年（イトラコナゾール、パチデギブ塩酸塩、REM-001、TG-1042、トリファロテン、その他） ・世界の基底細胞母斑症候群治療薬市場：種類別市場規模予測 2021年-2026年（イトラコナゾール、パチデギブ塩酸塩、REM-001、TG-1042、トリファロテン、その他） ・世界の基底細胞母斑症候群治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の基底細胞母斑症候群治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の基底細胞母斑症候群治療薬市場分析：米国、カナダ ・ヨーロッパの基底細胞母斑症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの基底細胞母斑症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の基底細胞母斑症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの基底細胞母斑症候群治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adgero Biopharmaceuticals Holdings Inc、Galderma SA、Mayne Pharma Group Ltd、PellePharm Inc、Transgene SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Basal Cell Nevus Syndrome Drug Market
The global Basal Cell Nevus Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Basal Cell Nevus Syndrome Drug Scope and Market Size
Basal Cell Nevus Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Nevus Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Basal Cell Nevus Syndrome Drug market is segmented into
Itraconazole
Patidegib Hydrochloride
REM-001
TG-1042
Trifarotene
Others
Segment by Application, the Basal Cell Nevus Syndrome Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Basal Cell Nevus Syndrome Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Basal Cell Nevus Syndrome Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Basal Cell Nevus Syndrome Drug Market Share Analysis
Basal Cell Nevus Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Basal Cell Nevus Syndrome Drug business, the date to enter into the Basal Cell Nevus Syndrome Drug market, Basal Cell Nevus Syndrome Drug product introduction, recent developments, etc.
The major vendors covered:
Adgero Biopharmaceuticals Holdings Inc
Galderma SA
Mayne Pharma Group Ltd
PellePharm Inc
Transgene SA
…
1 Study Coverage
1.1 Basal Cell Nevus Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Basal Cell Nevus Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Basal Cell Nevus Syndrome Drug Market Size Growth Rate by Type
1.4.2 Itraconazole
1.4.3 Patidegib Hydrochloride
1.4.4 REM-001
1.4.5 TG-1042
1.4.6 Trifarotene
1.4.7 Others
1.5 Market by Application
1.5.1 Global Basal Cell Nevus Syndrome Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Basal Cell Nevus Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Basal Cell Nevus Syndrome Drug Revenue 2015-2026
2.1.2 Global Basal Cell Nevus Syndrome Drug Sales 2015-2026
2.2 Global Basal Cell Nevus Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Basal Cell Nevus Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Basal Cell Nevus Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Basal Cell Nevus Syndrome Drug Competitor Landscape by Players
3.1 Basal Cell Nevus Syndrome Drug Sales by Manufacturers
3.1.1 Basal Cell Nevus Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Basal Cell Nevus Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Basal Cell Nevus Syndrome Drug Revenue by Manufacturers
3.2.1 Basal Cell Nevus Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Basal Cell Nevus Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Basal Cell Nevus Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Basal Cell Nevus Syndrome Drug Revenue in 2019
3.2.5 Global Basal Cell Nevus Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Basal Cell Nevus Syndrome Drug Price by Manufacturers
3.4 Basal Cell Nevus Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Basal Cell Nevus Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Basal Cell Nevus Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Basal Cell Nevus Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Basal Cell Nevus Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Basal Cell Nevus Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Basal Cell Nevus Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Basal Cell Nevus Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Basal Cell Nevus Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Basal Cell Nevus Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Basal Cell Nevus Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Basal Cell Nevus Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Basal Cell Nevus Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Basal Cell Nevus Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Basal Cell Nevus Syndrome Drug Price by Application (2015-2020)
5.2 Basal Cell Nevus Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Basal Cell Nevus Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Basal Cell Nevus Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Basal Cell Nevus Syndrome Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Basal Cell Nevus Syndrome Drug by Country
6.1.1 North America Basal Cell Nevus Syndrome Drug Sales by Country
6.1.2 North America Basal Cell Nevus Syndrome Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Basal Cell Nevus Syndrome Drug Market Facts & Figures by Type
6.3 North America Basal Cell Nevus Syndrome Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Basal Cell Nevus Syndrome Drug by Country
7.1.1 Europe Basal Cell Nevus Syndrome Drug Sales by Country
7.1.2 Europe Basal Cell Nevus Syndrome Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Basal Cell Nevus Syndrome Drug Market Facts & Figures by Type
7.3 Europe Basal Cell Nevus Syndrome Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Basal Cell Nevus Syndrome Drug by Region
8.1.1 Asia Pacific Basal Cell Nevus Syndrome Drug Sales by Region
8.1.2 Asia Pacific Basal Cell Nevus Syndrome Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Basal Cell Nevus Syndrome Drug Market Facts & Figures by Type
8.3 Asia Pacific Basal Cell Nevus Syndrome Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Basal Cell Nevus Syndrome Drug by Country
9.1.1 Latin America Basal Cell Nevus Syndrome Drug Sales by Country
9.1.2 Latin America Basal Cell Nevus Syndrome Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Basal Cell Nevus Syndrome Drug Market Facts & Figures by Type
9.3 Central & South America Basal Cell Nevus Syndrome Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Basal Cell Nevus Syndrome Drug by Country
10.1.1 Middle East and Africa Basal Cell Nevus Syndrome Drug Sales by Country
10.1.2 Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Basal Cell Nevus Syndrome Drug Market Facts & Figures by Type
10.3 Middle East and Africa Basal Cell Nevus Syndrome Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Adgero Biopharmaceuticals Holdings Inc
11.1.1 Adgero Biopharmaceuticals Holdings Inc Corporation Information
11.1.2 Adgero Biopharmaceuticals Holdings Inc Description and Business Overview
11.1.3 Adgero Biopharmaceuticals Holdings Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adgero Biopharmaceuticals Holdings Inc Basal Cell Nevus Syndrome Drug Products Offered
11.1.5 Adgero Biopharmaceuticals Holdings Inc Related Developments
11.2 Galderma SA
11.2.1 Galderma SA Corporation Information
11.2.2 Galderma SA Description and Business Overview
11.2.3 Galderma SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Galderma SA Basal Cell Nevus Syndrome Drug Products Offered
11.2.5 Galderma SA Related Developments
11.3 Mayne Pharma Group Ltd
11.3.1 Mayne Pharma Group Ltd Corporation Information
11.3.2 Mayne Pharma Group Ltd Description and Business Overview
11.3.3 Mayne Pharma Group Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mayne Pharma Group Ltd Basal Cell Nevus Syndrome Drug Products Offered
11.3.5 Mayne Pharma Group Ltd Related Developments
11.4 PellePharm Inc
11.4.1 PellePharm Inc Corporation Information
11.4.2 PellePharm Inc Description and Business Overview
11.4.3 PellePharm Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 PellePharm Inc Basal Cell Nevus Syndrome Drug Products Offered
11.4.5 PellePharm Inc Related Developments
11.5 Transgene SA
11.5.1 Transgene SA Corporation Information
11.5.2 Transgene SA Description and Business Overview
11.5.3 Transgene SA Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Transgene SA Basal Cell Nevus Syndrome Drug Products Offered
11.5.5 Transgene SA Related Developments
11.1 Adgero Biopharmaceuticals Holdings Inc
11.1.1 Adgero Biopharmaceuticals Holdings Inc Corporation Information
11.1.2 Adgero Biopharmaceuticals Holdings Inc Description and Business Overview
11.1.3 Adgero Biopharmaceuticals Holdings Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adgero Biopharmaceuticals Holdings Inc Basal Cell Nevus Syndrome Drug Products Offered
11.1.5 Adgero Biopharmaceuticals Holdings Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Basal Cell Nevus Syndrome Drug Market Estimates and Projections by Region
12.1.1 Global Basal Cell Nevus Syndrome Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Basal Cell Nevus Syndrome Drug Revenue Forecast by Regions 2021-2026
12.2 North America Basal Cell Nevus Syndrome Drug Market Size Forecast (2021-2026)
12.2.1 North America: Basal Cell Nevus Syndrome Drug Sales Forecast (2021-2026)
12.2.2 North America: Basal Cell Nevus Syndrome Drug Revenue Forecast (2021-2026)
12.2.3 North America: Basal Cell Nevus Syndrome Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Basal Cell Nevus Syndrome Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Basal Cell Nevus Syndrome Drug Sales Forecast (2021-2026)
12.3.2 Europe: Basal Cell Nevus Syndrome Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Basal Cell Nevus Syndrome Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Basal Cell Nevus Syndrome Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Basal Cell Nevus Syndrome Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Basal Cell Nevus Syndrome Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Basal Cell Nevus Syndrome Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Basal Cell Nevus Syndrome Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Basal Cell Nevus Syndrome Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Basal Cell Nevus Syndrome Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Basal Cell Nevus Syndrome Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Basal Cell Nevus Syndrome Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Basal Cell Nevus Syndrome Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Basal Cell Nevus Syndrome Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Basal Cell Nevus Syndrome Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Basal Cell Nevus Syndrome Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Basal Cell Nevus Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Basal Cell Nevus Syndrome Drug Market Segments
Table 2. Ranking of Global Top Basal Cell Nevus Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Basal Cell Nevus Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Itraconazole
Table 5. Major Manufacturers of Patidegib Hydrochloride
Table 6. Major Manufacturers of REM-001
Table 7. Major Manufacturers of TG-1042
Table 8. Major Manufacturers of Trifarotene
Table 9. Major Manufacturers of Others
Table 10. Global Basal Cell Nevus Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Basal Cell Nevus Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Basal Cell Nevus Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Basal Cell Nevus Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Basal Cell Nevus Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Basal Cell Nevus Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Basal Cell Nevus Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Basal Cell Nevus Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Nevus Syndrome Drug as of 2019)
Table 19. Basal Cell Nevus Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Basal Cell Nevus Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Basal Cell Nevus Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 22. Basal Cell Nevus Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Basal Cell Nevus Syndrome Drug Product Type
Table 24. Date of International Manufacturers Enter into Basal Cell Nevus Syndrome Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Basal Cell Nevus Syndrome Drug Sales Share by Type (2015-2020)
Table 28. Global Basal Cell Nevus Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Basal Cell Nevus Syndrome Drug Revenue Share by Type (2015-2020)
Table 30. Basal Cell Nevus Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Basal Cell Nevus Syndrome Drug Sales Share by Application (2015-2020)
Table 33. North America Basal Cell Nevus Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Basal Cell Nevus Syndrome Drug Sales Market Share by Country (2015-2020)
Table 35. North America Basal Cell Nevus Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Basal Cell Nevus Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Table 39. North America Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Basal Cell Nevus Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Basal Cell Nevus Syndrome Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Basal Cell Nevus Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Basal Cell Nevus Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Basal Cell Nevus Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Basal Cell Nevus Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Basal Cell Nevus Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Basal Cell Nevus Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Basal Cell Nevus Syndrome Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Basal Cell Nevus Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Basal Cell Nevus Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Table 73. Adgero Biopharmaceuticals Holdings Inc Corporation Information
Table 74. Adgero Biopharmaceuticals Holdings Inc Description and Major Businesses
Table 75. Adgero Biopharmaceuticals Holdings Inc Basal Cell Nevus Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Adgero Biopharmaceuticals Holdings Inc Product
Table 77. Adgero Biopharmaceuticals Holdings Inc Recent Development
Table 78. Galderma SA Corporation Information
Table 79. Galderma SA Description and Major Businesses
Table 80. Galderma SA Basal Cell Nevus Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Galderma SA Product
Table 82. Galderma SA Recent Development
Table 83. Mayne Pharma Group Ltd Corporation Information
Table 84. Mayne Pharma Group Ltd Description and Major Businesses
Table 85. Mayne Pharma Group Ltd Basal Cell Nevus Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Mayne Pharma Group Ltd Product
Table 87. Mayne Pharma Group Ltd Recent Development
Table 88. PellePharm Inc Corporation Information
Table 89. PellePharm Inc Description and Major Businesses
Table 90. PellePharm Inc Basal Cell Nevus Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. PellePharm Inc Product
Table 92. PellePharm Inc Recent Development
Table 93. Transgene SA Corporation Information
Table 94. Transgene SA Description and Major Businesses
Table 95. Transgene SA Basal Cell Nevus Syndrome Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Transgene SA Product
Table 97. Transgene SA Recent Development
Table 98. Global Basal Cell Nevus Syndrome Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 99. Global Basal Cell Nevus Syndrome Drug Sales Market Share Forecast by Regions (2021-2026)
Table 100. Global Basal Cell Nevus Syndrome Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 101. Global Basal Cell Nevus Syndrome Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 102. North America: Basal Cell Nevus Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. North America: Basal Cell Nevus Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Europe: Basal Cell Nevus Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Europe: Basal Cell Nevus Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Asia Pacific: Basal Cell Nevus Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 107. Asia Pacific: Basal Cell Nevus Syndrome Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 108. Latin America: Basal Cell Nevus Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Latin America: Basal Cell Nevus Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Middle East and Africa: Basal Cell Nevus Syndrome Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Middle East and Africa: Basal Cell Nevus Syndrome Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key Basal Cell Nevus Syndrome Drug Players
Table 116. Basal Cell Nevus Syndrome Drug Customers List
Table 117. Basal Cell Nevus Syndrome Drug Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Basal Cell Nevus Syndrome Drug Product Picture
Figure 2. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Itraconazole Product Picture
Figure 4. Patidegib Hydrochloride Product Picture
Figure 5. REM-001 Product Picture
Figure 6. TG-1042 Product Picture
Figure 7. Trifarotene Product Picture
Figure 8. Others Product Picture
Figure 9. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Others
Figure 13. Basal Cell Nevus Syndrome Drug Report Years Considered
Figure 14. Global Basal Cell Nevus Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Basal Cell Nevus Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Basal Cell Nevus Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Region in 2019
Figure 19. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Region in 2019
Figure 21. Global Basal Cell Nevus Syndrome Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Basal Cell Nevus Syndrome Drug Revenue in 2019
Figure 23. Basal Cell Nevus Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Type in 2019
Figure 26. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Type in 2019
Figure 28. Global Basal Cell Nevus Syndrome Drug Market Share by Price Range (2015-2020)
Figure 29. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Basal Cell Nevus Syndrome Drug Sales Market Share by Application in 2019
Figure 31. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Basal Cell Nevus Syndrome Drug Revenue Market Share by Application in 2019
Figure 33. North America Basal Cell Nevus Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Basal Cell Nevus Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Basal Cell Nevus Syndrome Drug Sales Market Share by Country in 2019
Figure 36. North America Basal Cell Nevus Syndrome Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Basal Cell Nevus Syndrome Drug Market Share by Type in 2019
Figure 42. North America Basal Cell Nevus Syndrome Drug Market Share by Application in 2019
Figure 43. Europe Basal Cell Nevus Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Basal Cell Nevus Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Basal Cell Nevus Syndrome Drug Sales Market Share by Country in 2019
Figure 46. Europe Basal Cell Nevus Syndrome Drug Revenue Market Share by Country in 2019
Figure 47. Germany Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Basal Cell Nevus Syndrome Drug Market Share by Type in 2019
Figure 58. Europe Basal Cell Nevus Syndrome Drug Market Share by Application in 2019
Figure 59. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Basal Cell Nevus Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Basal Cell Nevus Syndrome Drug Revenue Market Share by Region in 2019
Figure 63. China Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Basal Cell Nevus Syndrome Drug Market Share by Type in 2019
Figure 86. Asia Pacific Basal Cell Nevus Syndrome Drug Market Share by Application in 2019
Figure 87. Latin America Basal Cell Nevus Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Basal Cell Nevus Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Basal Cell Nevus Syndrome Drug Sales Market Share by Country in 2019
Figure 90. Latin America Basal Cell Nevus Syndrome Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Basal Cell Nevus Syndrome Drug Market Share by Type in 2019
Figure 98. Latin America Basal Cell Nevus Syndrome Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Basal Cell Nevus Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Basal Cell Nevus Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Basal Cell Nevus Syndrome Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Basal Cell Nevus Syndrome Drug Market Share by Application in 2019
Figure 111. North America Basal Cell Nevus Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Basal Cell Nevus Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Basal Cell Nevus Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Basal Cell Nevus Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Basal Cell Nevus Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Basal Cell Nevus Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Basal Cell Nevus Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Basal Cell Nevus Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Basal Cell Nevus Syndrome Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Basal Cell Nevus Syndrome Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
基底細胞がん（BCC）治療薬の世界市場（～2026年） Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…- レノックス・ガストー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lennox-Gastaut Syndrome Drug Scope and Market Size Lennox…
- トゥレット症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Tourette Syndrome Drug Market The global Tourette Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tourette Syndrome Drug Scope and Market Size Tourette Syndrome Drug m…
- 好酸球増加症候群薬の世界市場（～2026年） Market Analysis and Insights: Global Hypereosinophilic Syndrome Drug Market The global Hypereosinophilic Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypereosinophilic Syndrome Drug Scope and Market Si…
- 非定型溶血性尿毒症症候群薬の世界市場（～2026年） Market Analysis and Insights: Global Atypical Hemolytic Uremic Syndrome Drug Market The global Atypical Hemolytic Uremic Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Atypical Hemolytic Uremic Syndrome …